m6A甲基转移酶METTL3调控5'-isomiR-1261生成促进口腔鳞癌恶性进展的机制研究
批准号:
82073036
项目类别:
面上项目
资助金额:
55.0 万元
负责人:
郭海艳
依托单位:
学科分类:
肿瘤发生
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
郭海艳
中文摘要
研究证实,体内大多数高丰度表达的miRNA异构体(isomiRs)具有重要的生物学功能,许多疾病的致病机制与isomiRs的表达变化密切相关。人类口腔鳞癌中有关isomiRs的研究尚未见报道。我们前期研究发现:(1)口腔鳞癌组织中5'-isomiR-1261显著升高,并促进癌细胞的增殖、克隆形成及抑制细胞凋亡;(2)pri-miR-1261转录本中存在m6A修饰位点;(3)口腔鳞癌中METTL3基因表达升高,沉默METTL3表达导致RNA m6A修饰及5'-isomiR-1261表达水平降低。基于以上结果,我们提出假设:METTL3介导的RNA m6A修饰调控5'-isomiR-1261的合成,促进口腔鳞癌的发生发展。我们拟通过miCLIP及RNA测序等方法,在分子生物学、PDX模型以及临床样本等不同层面,深入研究isomiRs形成的分子机制及临床诊治价值,开辟isomiRs研究的新视野。
英文摘要
It is known that almost all miRNAs have isomiRs. Most high-abundance isomiRs in the body have important biological functions. The pathogenic mechanism of many diseases is closely related to isomiRs. Research on isomiRs in human oral squamous cell carcinoma (OSCC) has not been reported. Our previous research found that 5'-isomiR-1261 was significantly increased in oral squamous cell carcinoma tissues, and that the targets regulated by 5'-isomiR-1261 were significantly different from targets regulated by typical miR-1261. 5'-isomiR-1261 significantly promotes the proliferation, colony formation, and reduces the incidence of apoptosis of OSCC cells. Studies have initially confirmed that m6A modification exists in the pri-miR-1261 transcript. In addition, METTL3 gene expression was increased in OSCC tissues, and silencing of METTL3 gene expression resulted in a decrease in 5'-isomiR-1261 expression level. Based on the above results, we propose a scientific hypothesis: METTL3-mediated RNA m6A modification regulates 5'-isomiR-1261 biosynthesis and promotes the occurrence and progression of oral squamous cell carcinoma. We intend to use miCLIP, MeRIP-qPCR, RNA pull-down, and RIP methods to deeply study the molecular mechanism of isomRs formation and its clinical diagnostic and therapeutic value at different levels such as cell biology, PDX models, and clinical samples. Simultaneous research at the miRNA/isomiR level will help to further understand miRNA biosynthesis and precise regulation models, and open up new fields for miRNA research.
项目背景:.头颈肿瘤治疗面临的主要问题在于化疗耐药的形成以及免疫逃逸的发生,严重制约了化疗药物以及免疫检查点药物阻断剂的广泛应用。.主要研究内容:.(1)阐明Lnc-POP1-1增强DNA损伤修复活性促进HNSCC化疗耐药的机制;.(2)阐明线粒体拓扑异构酶TOP1MT调控HNSCC化疗耐药的全新机制;.(3)通过单细胞RNA测序鉴定CAFs调控CD8+ T细胞浸润的新机制;.(4)阐明肿瘤来源的sEVs在肺部驱动转移前微环境形成的机制;.(5)阐明核miR-451a通过转录激活KDM7A表达,促进HNSCC西妥昔单抗耐药的机制;.关键数据:.(1)我们揭示了HNSCC发生化疗耐药的全新机制:以TOP1MT为化疗耐药的关键介导分子,通过促进DNA损伤修复活性以及增强线粒体氧化磷酸化,多层面促进HNSCC化疗耐药的形成;.(2)我们阐明了HNSCC发生免疫逃逸的分子机制:以肿瘤相关成纤维细胞为关键,通过抑制CD8+T细胞的浸润,促进肿瘤免疫逃逸发生。.相关成果:.在本项目的支持下,项目负责人(郭海艳)发表SCI论文5篇,包括《Molecular Therapy》、《Cancer Research》、《Cancer Immunology Research》、《Cell Mol Life Sci》及《BMC Medicine》,所有论文均为JCR Q1区。如期完成了项目考核指标。.研究生培养:.本项目联合培养已毕业博士研究生1名(李楚文);已毕业硕士研究生2名(童桐、翟培淞);在读博士研究生1名(李姝);在读硕士研究生1名(刘纯)。
MHC-I(high)Galectin-9+CAFs诱导CD8+T细胞耗竭促进头颈鳞癌免疫逃逸的机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:郭海艳
-
依托单位:
PAX4-miR381-NRP2轴在结肠癌侵袭与转移中的作用
-
批准号:81201912
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:郭海艳
-
依托单位:
国内基金
海外基金